The Relationship between Statins and Prostate Cancer Prevention

Abstract

Prostate cancer is the most frequently diagnosed cancer among men in the United States, excluding non-melanoma skin cancer. Few risk factors and prevention strategies for prostate cancer are known. Some evidence suggests that statins, a class of medications that lower cholesterol, may reduce the incidence and progression of prostate cancer. Dr. Farwell obtained training that allowed him to investigate the relationship between statins and prostate cancer incidence and progression. He took classes at the Harvard School of Public Health and had regular research meetings with researchers at the Brigham and Women's Hospital and the VA Boston Healthcare System. He assembled datasets and performed analyses that examined the relationship between statins and total prostate cancer incidence as well as the incidence of both low and high grade prostate cancer.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2011
Accession Number
ADA553495

Entities

People

  • Wildon Farwell

Organizations

  • Brigham and Women's Hospital

Tags

DTIC Thesaurus Topics

  • Aneurysm
  • Cardiovascular Diseases
  • Cardiovascular Physiological Phenomena
  • Department Of Defense
  • Enzyme Inhibitors
  • Health Services
  • Medical Personnel
  • Oncology
  • Pharmacies
  • Prostate Cancer
  • Public Health
  • Statins
  • Students

Fields of Study

  • Medicine

Readers

  • Prostate Cancer Biology.
  • Research Science/Academic Research
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.